Licensing & Partnership
15.3M+ condition-confirmed patient inquiries. Every record is a real person who self-identified on a condition-specific intake — already past the impression, the click, and the form. The largest exclusive consented-intent asset in healthcare, licensed four different ways.
The Asset
The 15.3M figure isn't an audience built from third-party signals, modeled lookalikes, or impression-level proxies. Every record is a real person who completed the work a pharma campaign is built to drive — they saw an unbranded condition ad, clicked through, and either filled out a condition-specific landing page or called in through a click-to-call or live transfer line. They self-identified. They gave consent. They asked for information.
That's the action a brand's entire media budget is trying to produce. Squyr already produced it — across a decade of unbranded campaigns, at scale no competitor can replicate, exclusive for 20 years.
T1's 140,216 Tx-verified patients, T2's 218,071 Dx-qualified records, the 386,000+ cross-tier matches, and 1,008,348 Rx fulfillment events are proof T3 converts downstream — not the headline asset. The headline asset is T3.
The Four Structures
Every Squyr license includes the same operational foundation — the data layer, Squyr identity protocol, and access to Squyr Exchange for activation. What differs is the scope of exclusivity, the commercial terms, and the competitive lockout against other licensees in your category.
Exclusive access to the full Squyr dataset across every condition, every tier, and every derivative segment. No other commercial party — pharma, agency, holding company, or platform — accesses Squyr's data during the license term. The strongest competitive position available; structured for partners building a category-defining asset where data exclusivity is the moat itself.
Exclusive rights within a defined therapeutic vertical — for example, Diabetes, Sleep Apnea, GLP-1/Obesity, or Cardiac. Inside your category, no other licensee accesses the data. Other categories remain available to other partners under separate agreements. The structure most brands and DSPs choose when they want a defensible competitive position without acquiring the entire data layer.
Licensed access to specific segments, tiers, or use cases without exclusivity. The fastest path from contract to activation — appropriate for brands running defined campaigns, agencies executing on behalf of clients, and partners testing audience performance before committing to a deeper structure. Standard BAA, standard terms, standard activation timeline.
Strategic distribution agreements where the partner enriches, re-packages, or resells Squyr data through their own channels — DSPs, data graphs, identity vendors, healthcare platforms — under a defined revenue-share structure. Squyr retains data ownership; partner owns the distribution surface and the client relationship. Terms are structured per partnership economics, with attribution and audit built in by default.
Operational Foundation
At a Glance
| Full Exclusive | Category Exclusive | Non-Exclusive | Partnership / Rev-Share | |
|---|---|---|---|---|
| Exclusivity | Entire dataset | Within category | None | Per agreement |
| Competitive lockout | All commercial parties | Within category | None | Per channel/territory |
| Term length | Up to 20 years | Multi-year | Per-campaign / annual | Multi-year |
| Squyr included | Yes | Yes | Yes | Yes |
| Data scope | Full T3 + all proof tiers | T3 + proof tiers, in category | Defined segment(s) | Per agreement |
| Pricing model | Custom premium | Custom by category | Per-segment / per-campaign | Net rev share |
| Time to activation | 60–90 days | 30–60 days | 7–14 days | Per structure |
| Best fit | Strategic acquirers | Category leader | Single-campaign brand | Distribution partner |
From Conversation to Activation
The right structure depends on what you're trying to build. A scoping call is the fastest way to find out. We'll walk through your target conditions, audience needs, and competitive context — and return a structure recommendation within one week.